journal article·2018-06-13

Biocompatibility and anticancer activity of L-phenyl alanine-coated iron oxide magnetic nanoparticles as potential chrysin delivery system

Hamed Nosrati, Elham Javani, Marziyeh Salehiabar, Hamidreza Kheiri Manjili, Soodabeh Davaran, Hossein Danafar

Journal of Materials Research· Volume 33· Issue 11
Publisher page

Abstract

In this project, we described the production of chrysin-loaded L-phenyl alanine (Phe)-coated iron oxide magnetic nanoparticles (chrysin@Phe@IOMNs). chrysin@Phe@IOMNs were characterized by X-ray diffraction, thermogravimetric analysis, fourier transform infrared spectroscopy, vibrating sample magnetometer, and transmission electron microscopy techniques. Next, hemocompatibility and biocompatibility of Phe-coated IOMNs were determined by hemolysis and MTT assays on HFF-2 and HEK-293 cell lines, respectively. Finally, the anticancer activity of chrysin@Phe@IOMNs was examined on MCF-7 cell line. The outcomes direct that as-prepared nanocarriers are nontoxic and biocompatible and also chrysin@Phe@IOMNs are appropriate for chrysin delivery and other hydrophobic therapeutic agents.
Source: expertdata · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Flavonoids in Medical Research · Curcumin's Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (35)

Show source-provided references
1. 10.1039/B917195A10.1039/B917195A ↗
2. 10.1016/j.jallcom.2009.04.10310.1016/j.jallcom.2009.04.103 ↗
3. 10.1039/C6NJ03332F10.1039/C6NJ03332F ↗
4. 10.1002/jbm.a.3636410.1002/jbm.a.36364 ↗
5. 10.1002/aoc.406910.1002/aoc.4069 ↗
6. 10.1021/acs.jpcc.6b0318010.1021/acs.jpcc.6b03180 ↗
7. 10.1016/j.cap.2008.08.02710.1016/j.cap.2008.08.027 ↗
8. 10.1016/j.matlet.2008.10.05710.1016/j.matlet.2008.10.057 ↗
9. 10.1039/C3TB21171A10.1039/C3TB21171A ↗
10. 10.1016/j.colsurfa.2013.08.04410.1016/j.colsurfa.2013.08.044 ↗
11. 10.1039/C5CS00541H10.1039/C5CS00541H ↗
12. 10.1007/s10904-017-0758-710.1007/s10904-017-0758-7 ↗
13. 10.3109/10717544.2013.87383710.3109/10717544.2013.873837 ↗
14. 10.1007/s40005-013-0098-810.1007/s40005-013-0098-8 ↗
15. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
16. 10.3109/0284186920908890210.3109/02841869209088902 ↗
17. Chrysin-loaded PLGA-PEG nanoparticles designed for enhanced effect on the breast cancer cell line10.3109/21691401.2015.1029633 ↗
18. 10.1016/j.bmcl.2005.09.00910.1016/j.bmcl.2005.09.009 ↗
19. 10.1016/j.bioorg.2017.12.03310.1016/j.bioorg.2017.12.033 ↗
20. 10.15171/apb.2015.07410.15171/apb.2015.074 ↗
21. 10.1039/c1nr10326a10.1039/c1nr10326a ↗
22. 10.1007/s11164-017-3204-010.1007/s11164-017-3204-0 ↗
23. 10.1016/j.ejpb.2014.03.01110.1016/j.ejpb.2014.03.011 ↗
24. 10.1039/C6RA00102E10.1039/C6RA00102E ↗
25. Development and characterization dual responsive magnetic nanocomposites for targeted drug delivery systems
26. 10.1097/00001648-199503000-0000910.1097/00001648-199503000-00009 ↗
27. 10.1016/j.apsusc.2015.11.25210.1016/j.apsusc.2015.11.252 ↗
28. Facile synthesis and characterization of l-aspartic acid coated iron oxide magnetic nanoparticles (IONPs) for biomedical applications10.1055/s-0043-120197 ↗
29. 10.1039/c2cs15315g10.1039/c2cs15315g ↗
30. 10.1080/21691401.2016.122865810.1080/21691401.2016.1228658 ↗
31. 10.1016/S0304-8853(00)01229-410.1016/S0304-8853(00)01229-4 ↗
32. 10.1016/j.ica.2012.01.05810.1016/j.ica.2012.01.058 ↗
33. 10.1007/s11164-013-1484-610.1007/s11164-013-1484-6 ↗
34. 10.1021/acs.jpcc.5b0719510.1021/acs.jpcc.5b07195 ↗
35. 10.1016/j.ijbiomac.2018.04.04310.1016/j.ijbiomac.2018.04.043 ↗